McCall McPhersonFounder, Modern Thyroid Clinic.

GLP-1s: Unlock Longer Life & Fight Heart Disease! #shorts

15 Oct 2026 · 1 min

Watch on YouTube

0:34

In this concise YouTube short, McCall McPherson explains how GLP‑1 based therapies can significantly extend both healthspan and lifespan. He cites study‑derived estimates that GLP‑1 treatment reduces overall mortality by roughly 12‑18% and cuts the risk of major cardiovascular events—heart attacks or strokes—by 25‑39%, depending on the specific study and the underlying mechanism. Emphasizing that cardiovascular disease is the leading cause of death, he argues that these risk reductions directly translate into longer, healthier lives.

Chapters

And if we can intervene at those 2 points, we can improve our healthspan, we can improve our lifespan. But I think the data backs it up, right? Like, our chance of dying on a GLP is 12% to 18% less. That's pretty remarkable. Our chance of dying or having a cardiovascular event, like a heart attack or stroke, is 25% to 39% less likely to happen, depending on the study, depending on what the mechanism of cardiovascular event is. So if that's the number one cause that most of us are going to die from in this room, how could it not impact longevity?